Top Markets
Coin of the day
Aarti Pharmalabs Limited Aarti Pharmalabs Limited

Aarti Pharmalabs Limited

AARTIPHARM
Rangering i aksjer #10430
Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and... Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides contract development and manufacturing services for drug substance projects. In addition, the company offers intermediates; xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline; and acid and allied products, including sulphuric acid, sulphur trioxide, oil, dimethyl sulphate, diethyl sulphate, and sodium vinyl sulfonate. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is headquartered in Mumbai, India.
Aksjekurs
$9.28
Sist synkronisert: 2026-08-28
Markedsverdi
$841.31M
Endring (1 dag)
3.34%
Endring (1 år)
-2.77%
Land
IN
Handel Aarti Pharmalabs Limited (AARTIPHARM)

Kategori

Antall utestående aksjer for Aarti Pharmalabs Limited (AARTIPHARM)
Antall utestående aksjer per August 2026: 0
Ifølge Aarti Pharmalabs Limited sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 0. Ved slutten av August 2026 hadde selskapet 0 utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Aarti Pharmalabs Limited (AARTIPHARM) fra 2026 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
Ikke nok data for de angitte datoene.
Utestående aksjer for lignende selskaper eller konkurrenter